Prediction: Here's What a $5,000 Investment in Marvell Could Be Worth by 2030 Marvell Technology stock has multibagger potential even after rising substantially over the past year.
Canada’s Talking Up Uranium: Is Cameco a Good Stock to Buy Now? Cameco is a leading uranium producer and well- positioned to benefit from growing demand and expected increase in prices.
I Plan to Keep These Stocks in My TFSA for at Least 10 Years These TFSA stocks combine income, stability, and growth, giving me three different reasons to hold them for at least 10 years.
Kroger EVP Mary Ellen Adcock Sells 72,901 Shares for $4.4 Million Adcock exercised nearly 49,000 stock options at $38.32 before liquidating a larger block, capturing the spread between grant and market prices. She retains ~175,000 shares worth $10.51 million.
Prediction: This Is What Will Happen With Berkshire Hathaway Stock in the Next 12 Months The stock's underwhelming performance this year could be the early stages of an even greater decline.
Dollarama Stock Is Soaring After a Blowout Quarter: Is It a Buy Today? Given its solid and reliable financial performance and multiple growth avenues, Dollarama would be an excellent buy for long-term investors.
Brookfield Just Launched a $50 Billion Canada Fund: Should You Buy BAM Stock? Brookfield and CPP just unveiled a $50 billion “Maple Fund.” It’s a reminder that Brookfield gets the call when Canada needs billions deployed at once.
5 Dividend Stocks I’d Trust to Keep Paying Me No Matter What The five Canadian stocks have a solid earnings base and are positioned to keep paying their shareholders across all market conditions.
1 of the Most Reliable Payouts You Can Earn Isn’t From Your Job You can earn dividend income from ETFs like iShares S&P/TSX Capped Composite Index Fund (TSX:XIC).
Why Intuitive Machines Stock Just Popped Lanteris gave Intuitive Machines a giant new revenue stream. Now it looks buyable again.
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand ResMed (
NYSE:RMD ) outlined its growth outlook, margin strategy and portfolio plans during a Morgan Stanley discussion, with executives emphasizing demand generation, patient adherence and ongoing product innovation in sleep and respiratory care.
Chairman and Chief Executive Officer Mick Farrell sai
Why Settle for 2% When This Stock Pays Double? A savings account pays about 2% right now. This Canadian dividend stock pays nearly double, with 17 straight years of raises behind it.
Is Telus Still a Buy Right Now? Here’s My Verdict Telus slashed its dividend by 55% and the stock is hovering near April 2017 lows. Here's my honest verdict on whether it's a buy today.
Better AI Data Center Stock: Nebius vs. CoreWeave Which of these neocloud stocks is a better buy right now?
This Is the Canadian Dividend Stock I’d Hold in Any Market Canadian Utilities is a Canadian dividend stock with a 3.62% yield and 54 years of dividend growth through changing markets.
Buy These Canadian Dividend Superstars on a Pullback These companies have delivered annual dividend growth for decades.
Prediction: This Data Center Stock Will Be the AI Supercycle's Biggest Winner -- and It's Not a Household Name The demand for optical networking components is poised to boom, and Lumentum is one of the best ways to capitalize on this lucrative niche.
3 TSX Stocks to Buy With $1,000 This September Got $1,000 to deploy this September? Here's a small-, medium-, and large-cap TSX stock to buy right now.
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth Abbott leads in absolute revenue, but Intuitive Surgical's growth rate tells a different story over the past eight quarters.
Archer Aviation vs. Rocket Lab: Which Aerospace Stock Is a Better Buy in 2026? Archer is racing toward FAA certification with Boeing backing, while Rocket Lab is already generating revenue but faces integration risks.
